{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:09:16Z","timestamp":1785290956622,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell&apos;Istruzione, dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2010-2011 - 2010MCLPLB"],"award-info":[{"award-number":["PRIN 2010-2011 - 2010MCLPLB"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell&apos;Istruzione, dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Programma SIR\u2013RBSI14GPBL"],"award-info":[{"award-number":["Programma SIR\u2013RBSI14GPBL"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFAG2015 Id.17442"],"award-info":[{"award-number":["MFAG2015 Id.17442"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG13314"],"award-info":[{"award-number":["IG13314"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["Gilead Fellowship Program 2015"],"award-info":[{"award-number":["Gilead Fellowship Program 2015"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As previously reported, chronic lymphocytic leukemia (CLL) cells show constitutive Notch1\/2 activation and express the Notchligand Jagged1. Despite increasing knowledge of the impact of Notch alterations on CLL biology and pathogenesis, the role of Jagged1 expressed in CLL cells remains undefined. In other cell types, it has been shown that after Notch engagement, Jagged1 not only activates Notch in signal-receiving cell, but also undergoes proteolytic activation in signal-sending cell, triggering a signaling with biological effects. We investigated whether Jagged1 expressed in CLL cells undergoes proteolytic processing and\/or is able to induce Notch activation through autocrine\/paracrine loops, focusing on the effect that CLL prosurvival factor IL-4 could exert on the Notch-Jagged1 system in these cells. We found that Jagged1 was constitutively processed in CLL cells and generated an intracellular fragment that translocated into the nucleus, and an extracellular fragment released into the culture supernatant. IL-4 enhanced expression of Jagged1 and its intracellular fragments, as well as Notch1\/2 activation. The IL-4-induced increase in Notch1\/2 activation was independent of the concomitant upregulated Jagged1 levels. Indeed, blocking Notch-Jagged1 interactions among CLL cells with Jagged1 neutralizing antibodies did not affect the expression of the Notch target Hes1. Notably, anti-Jagged1 antibodies partially prevented the IL-4-induced increase in Jagged1 processing and cell viability, suggesting that Jagged1 processing is one of the events contributing to IL-4-induced CLL cell survival. Consistent with this, Jagged1 silencing by small interfering RNA partially counteracted the capacity of IL-4 to promote CLL cell survival. Investigating the pathways whereby IL-4 promoted Notch1\/2 activation in CLL cells independent of Jagged1, we found that PI3K\u03b4\/AKT and PKC\u03b4 were involved in upregulating Notch1 and Notch2 proteins, respectively. Overall, this study provides new insights into the Notch-ligand system in CLL cells and suggests that targeting this system may be exploited as a novel\/additional therapy approach for CLL.<\/jats:p>","DOI":"10.1038\/s41419-018-1185-6","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T09:38:14Z","timestamp":1543225094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["IL-4-dependent Jagged1 expression\/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation"],"prefix":"10.1038","volume":"9","author":[{"given":"Filomena","family":"De Falco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Del Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Baldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Falzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Di Ianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Mezzasoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pelullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sportoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Screpanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-123X","authenticated-orcid":false,"given":"Emanuela","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science 284, 770\u2013776 (1999).","journal-title":"Science"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1242\/dev.063610","volume":"138","author":"ER Andersson","year":"2011","unstructured":"Andersson, E. R., Sandberg, R. & Lendahl, U. Notch signaling: simplicity in design, versatility in function. Development 138, 3593\u20133612 (2011).","journal-title":"Development"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216\u2013233 (2009).","journal-title":"Cell"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00018-008-7586-4","volume":"65","author":"A Zolkiewska","year":"2008","unstructured":"Zolkiewska, A. ADAM proteases: ligand processing and modulation of the Notch pathway. Cell. Mol. Life Sci. 65, 2056\u20132068 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1038\/onc.2008.229","volume":"27","author":"B D\u2019Souza","year":"2008","unstructured":"D\u2019Souza, B., Miyamoto, A. & Weinmaster, G. The many facets of Notch ligands. Oncogene 27, 5148\u20135167 (2008).","journal-title":"Oncogene"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"34427","DOI":"10.1074\/jbc.M302659200","volume":"278","author":"MJ LaVoie","year":"2003","unstructured":"LaVoie, M. J. & Selkoe, D. J. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin\/gamma-secretase and release signaling fragments. J. Biol. Chem. 278, 34427\u201334437 (2003).","journal-title":"J. Biol. Chem."},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1074\/jbc.C200711200","volume":"278","author":"T Ikeuchi","year":"2003","unstructured":"Ikeuchi, T. & Sisodia, S. S. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent \u201cgamma-secretase\u201d cleavage. J. Biol. Chem. 278, 7751\u20137754 (2003).","journal-title":"J. Biol. Chem."},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"7638","DOI":"10.1073\/pnas.1230693100","volume":"100","author":"E Six","year":"2003","unstructured":"Six, E. et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc. Natl Acad. Sci. USA 100, 7638\u20137643 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"13607","DOI":"10.1074\/jbc.C300016200","volume":"278","author":"CE Bland","year":"2003","unstructured":"Bland, C. E., Kimberly, P. & Rand, M. D. Notch-induced proteolysis and nuclear localization of the Delta ligand. J. Biol. Chem. 278, 13607\u201313610 (2003).","journal-title":"J. Biol. Chem."},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.1074\/jbc.M211427200","volume":"78","author":"JM Ascano","year":"2003","unstructured":"Ascano, J. M., Beverly, L. J. & Capobianco, A. J. The C-terminal PDZ-ligand of JAGGED1 is essential for cellular transformation. J. Biol. Chem. 78, 8771\u20138779 (2003).","journal-title":"J. Biol. Chem."},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.neo.2014.10.004","volume":"16","author":"M Pelullo","year":"2014","unstructured":"Pelullo, M. et al. Notch3\/Jagged1 circuitry reinforces notch signaling and sustains T-ALL. Neoplasia 16, 1007\u20131017 (2014).","journal-title":"Neoplasia"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-04-2500","volume":"64","author":"S Santagata","year":"2004","unstructured":"Santagata, S. et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64, 6854\u20136857 (2004).","journal-title":"Cancer Res"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/jop.12013","volume":"42","author":"TH Zhang","year":"2013","unstructured":"Zhang, T. H. et al. Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo. J. Oral. Pathol. Med. 42, 322\u2013331 (2013).","journal-title":"J. Oral. Pathol. Med."},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jjco\/hyq205","volume":"41","author":"K Wu","year":"2011","unstructured":"Wu, K., Xu, L., Zhang, L., Lin, Z. & Hou, J. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma. Jpn. J. Clin. Oncol. 41, 411\u2013416 (2011).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1016\/j.cub.2010.10.034","volume":"21","author":"D del \u00c1lamo","year":"2011","unstructured":"del \u00c1lamo, D., Rouault, H. & Schweisguth, F. Mechanism and significance of cis-inhibition in Notch signalling. Curr. Biol. 21, R40\u2013R47 (2011).","journal-title":"Curr. Biol."},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.yexcr.2011.07.014","volume":"317","author":"MY Kim","year":"2011","unstructured":"Kim, M. Y. et al. The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase. Exp. Cell Res. 317, 2438\u20132446 (2011).","journal-title":"Exp. Cell Res."},{"key":"1185_CR17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.18632\/oncotarget.2762","volume":"6","author":"KJ Lim","year":"2015","unstructured":"Lim, K. J. et al. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget 6, 1666\u20131677 (2015).","journal-title":"Oncotarget"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1182\/blood-2005-08-3329","volume":"107","author":"KG Leong","year":"2006","unstructured":"Leong, K. G. & Karsan, A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 107, 2223\u20132233 (2006).","journal-title":"Blood"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi, N., Rai, K. R. & Ferrarini, M. Chronic lymphocytic leukemia. N. Engl. J. Med. 352, 804\u2013815 (2005).","journal-title":"N. Engl. J. Med."},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.8","volume":"16","author":"G Fabbri","year":"2016","unstructured":"Fabbri, G. & Dalla-Favera, R. The molecular pathogenesis of chronic lymphocytic leukaemia. Nat. Rev. Cancer 16, 145\u2013162 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1185_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/asheducation-2011.1.96","volume":"2011","author":"JA Burger","year":"2011","unstructured":"Burger, J. A. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematol. Am. Soc. Hematol. Educ. Program. 2011, 96\u2013103 (2011).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"1185_CR22","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","volume":"114","author":"AV Kurtova","year":"2009","unstructured":"Kurtova, A. V. et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114, 4441\u20134450 (2009).","journal-title":"Blood"},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","volume":"113","author":"E Rosati","year":"2009","unstructured":"Rosati, E. et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 113, 856\u2013865 (2009).","journal-title":"Blood"},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/ijc.27863","volume":"132","author":"E Rosati","year":"2013","unstructured":"Rosati, E. et al. \u03b3-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. Int. J. Cancer 132, 1940\u20131953 (2013).","journal-title":"Int. J. Cancer"},{"key":"1185_CR25","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.18632\/oncotarget.4116","volume":"6","author":"F De Falco","year":"2015","unstructured":"De Falco, F. et al. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL. Oncotarget 6, 16559\u201316572 (2015).","journal-title":"Oncotarget"},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/leu.2013.319","volume":"28","author":"F Arruga","year":"2014","unstructured":"Arruga, F. et al. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia 28, 1060\u20131070 (2014).","journal-title":"Leukemia"},{"key":"1185_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/leu.2014.329","volume":"29","author":"F De Falco","year":"2015","unstructured":"De Falco, F. et al. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. Leukemia 29, 994\u2013998 (2015).","journal-title":"Leukemia"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","volume":"146","author":"M Di Ianni","year":"2009","unstructured":"Di Ianni, M. et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br. J. Haematol. 146, 689\u2013691 (2009).","journal-title":"Br. J. Haematol."},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2010.08368.x","volume":"151","author":"P Sportoletti","year":"2010","unstructured":"Sportoletti, P. et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br. J. Haematol. 151, 404\u2013406 (2010).","journal-title":"Br. J. Haematol."},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101\u2013105 (2011).","journal-title":"Nature"},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119, 521\u2013529 (2012).","journal-title":"Blood"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/leu.2013.289","volume":"28","author":"P Sportoletti","year":"2014","unstructured":"Sportoletti, P. et al. A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia. Leukemia 28, 436\u2013439 (2014).","journal-title":"Leukemia"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"E2911","DOI":"10.1073\/pnas.1702564114","volume":"114","author":"G Fabbri","year":"2017","unstructured":"Fabbri, G. et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 114, E2911\u2013E2919 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.3324\/haematol.2014.117705","volume":"100","author":"A Onaindia","year":"2015","unstructured":"Onaindia, A. et al. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation. Haematologica 100, e200\u2013e203 (2015).","journal-title":"Haematologica"},{"key":"1185_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2012.17","volume":"2","author":"AH Nwabo Kamdje","year":"2012","unstructured":"Nwabo Kamdje, A. H. et al. Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. Blood Cancer J. 2, e73 (2012).","journal-title":"Blood Cancer J."},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1600-0609.2002.01612.x","volume":"68","author":"ED Rossmann","year":"2002","unstructured":"Rossmann, E. D., Lewin, N., Jeddi-Tehrani, M., Osterborg, A. & Mellstedt, H. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur. J. Haematol. 68, 299\u2013306 (2002).","journal-title":"Eur. J. Haematol."},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"e109533","DOI":"10.1371\/journal.pone.0109533","volume":"9","author":"N Ruiz-Lafuente","year":"2014","unstructured":"Ruiz-Lafuente, N. et al. The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NF\u03baB inhibitor. PLoS One 9, e109533 (2014).","journal-title":"PLoS One"},{"key":"1185_CR38","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1182\/blood.V99.8.2969","volume":"99","author":"M Barrag\u00e1n","year":"2002","unstructured":"Barrag\u00e1n, M. et al. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99, 2969\u20132976 (2002).","journal-title":"Blood"},{"key":"1185_CR39","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1084\/jem.176.5.1319","volume":"176","author":"M Dancescu","year":"1992","unstructured":"Dancescu, M. et al. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J. Exp. Med. 176, 1319\u20131326 (1992).","journal-title":"J. Exp. Med."},{"key":"1185_CR40","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1182\/blood-2009-09-245811","volume":"116","author":"AJ Steele","year":"2010","unstructured":"Steele, A. J. et al. The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment. Blood 116, 4569\u20134577 (2010).","journal-title":"Blood"},{"key":"1185_CR41","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1182\/blood-2015-11-682906","volume":"127","author":"MM Aguilar-Hernandez","year":"2016","unstructured":"Aguilar-Hernandez, M. M. et al. IL-4 enhances expression and function of surface IgM in CLL cells. Blood 127, 3015\u20133025 (2016).","journal-title":"Blood"},{"key":"1185_CR42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood-2015-11-682997","volume":"128","author":"B Guo","year":"2016","unstructured":"Guo, B., Zhang, L., Chiorazzi, N. & Rothstein, T. L. IL-4 rescues surface IgM expression in chronic lymphocytic leukemia. Blood 128, 553\u2013562 (2016).","journal-title":"Blood"},{"key":"1185_CR43","doi-asserted-by":"publisher","first-page":"e67306","DOI":"10.1371\/journal.pone.0067306","volume":"8","author":"MJ Kluk","year":"2013","unstructured":"Kluk, M. J. et al. Gauging NOTCH1 activation in cancer using immunohistochemistry. PLoS One 8, e67306 (2013).","journal-title":"PLoS One"},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2012.12.021","volume":"23","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 23, 171\u2013185 (2013).","journal-title":"Cancer Cell"},{"key":"1185_CR45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbrc.2013.02.022","volume":"432","author":"M Coglievina","year":"2013","unstructured":"Coglievina, M., Guarnaccia, C., Zlatev, V., Pongor, S. & Pintar, A. Jagged-1 juxtamembrane region: biochemical characterization and cleavage by ADAM17 (TACE) catalytic domain. Biochem. Biophys. Res. Commun. 432, 666\u2013671 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1185_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BJ20100321","volume":"432","author":"CA Parr-Sturgess","year":"2010","unstructured":"Parr-Sturgess, C. A., Rushton, D. J. & Parkin, E. T. Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event. Biochem. J. 432, 283\u2013294 (2010).","journal-title":"Biochem. J."},{"key":"1185_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini, A. et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk. Res. 23, 127\u2013136 (1999).","journal-title":"Leuk. Res."},{"key":"1185_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3892\/etm.2012.633","volume":"4","author":"E Kanamori","year":"2012","unstructured":"Kanamori, E. et al. Flow cytometric analysis of Notch1 and Jagged1 expression in normal blood cells and leukemia cells. Exp. Ther. Med 4, 397\u2013400 (2012).","journal-title":"Exp. Ther. Med"},{"key":"1185_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.seminoncol.2016.02.004","volume":"43","author":"JR Brown","year":"2016","unstructured":"Brown, J. R. The PI3K pathway: clinical inhibition in chronic lymphocytic leukemia. Semin. Oncol. 43, 260\u2013264 (2016).","journal-title":"Semin. Oncol."},{"key":"1185_CR50","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1182\/blood-2012-05-423194","volume":"120","author":"A Wiestner","year":"2012","unstructured":"Wiestner, A. Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Blood 120, 4684\u20134691 (2012).","journal-title":"Blood"},{"key":"1185_CR51","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","volume":"116","author":"SE Herman","year":"2010","unstructured":"Herman, S. E. et al. Phosphatidylinositol 3-kinase-\u03b4 inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood 116, 2078\u20132088 (2010).","journal-title":"Blood"},{"key":"1185_CR52","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood-2013-11-535047","volume":"123","author":"JR Brown","year":"2014","unstructured":"Brown, J. R. et al. Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110\u03b4, for relapsed\/refractory chronic lymphocytic leukemia. Blood 123, 3390\u20133397 (2014).","journal-title":"Blood"},{"key":"1185_CR53","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/gcc.22264","volume":"54","author":"N Platonova","year":"2015","unstructured":"Platonova, N. et al. PI3K\/AKT signaling inhibits NOTCH1 lysosome-mediated degradation. Genes Chromosomes Cancer 54, 516\u2013526 (2015).","journal-title":"Genes Chromosomes Cancer"},{"key":"1185_CR54","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1365-2141.2009.08024.x","volume":"148","author":"R Hubmann","year":"2010","unstructured":"Hubmann, R. et al. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells. Br. J. Haematol. 148, 868\u2013878 (2010).","journal-title":"Br. J. Haematol."},{"key":"1185_CR55","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.leu.2404113","volume":"20","author":"I Ringshausen","year":"2006","unstructured":"Ringshausen, I. et al. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL. Leukemia 20, 514\u2013520 (2006).","journal-title":"Leukemia"},{"key":"1185_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/bbrc.2001.5723","volume":"288","author":"K Ikizawa","year":"2001","unstructured":"Ikizawa, K., Kajiwara, K., Izuhara, K. & Yanagihara, Y. PKCdelta and zeta mediate IL-4\/IL-13-induced germline epsilon transcription in human Bcells: a putative regulation via PU.1 phosphorylation. Biochem. Biophy. Res. Commun. 288, 34\u201341 (2001).","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"1185_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0070-2153(10)92003-6","volume":"92","author":"B D\u2019Souza","year":"2010","unstructured":"D\u2019Souza, B., Meloty-Kapella, L. & Weinmaster, G. Canonical and non-canonical Notch ligands. Curr. Top. Dev. Biol. 92, 73\u2013129 (2010).","journal-title":"Curr. Top. Dev. Biol."},{"key":"1185_CR58","doi-asserted-by":"publisher","first-page":"17766","DOI":"10.1074\/jbc.M109.003111","volume":"284","author":"K Choi","year":"2009","unstructured":"Choi, K. et al. Distinct biological roles for the Notch ligands Jagged-1 and Jagged-2. J. Biol. Chem. 284, 17766\u201317774 (2009).","journal-title":"J. Biol. Chem."},{"key":"1185_CR59","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1073\/pnas.0813221106","volume":"106","author":"V Rodilla","year":"2009","unstructured":"Rodilla, V. et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc. Natl Acad. Sci. USA 106, 6315\u20136320 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1185_CR60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.18632\/oncotarget.127","volume":"1","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. Jagged1 expression regulated by Notch3 and Wnt\/\u03b2-catenin signaling pathways in ovarian cancer. Oncotarget 1, 210\u2013218 (2010).","journal-title":"Oncotarget"},{"key":"1185_CR61","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tcb.2015.07.010","volume":"25","author":"WH Palmer","year":"2015","unstructured":"Palmer, W. H. & Deng, W. M. Ligand-independent mechanisms of Notch activity. Trends Cell Biol. 25, 697\u2013707 (2015).","journal-title":"Trends Cell Biol."},{"key":"1185_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0070-2153(10)92005-X","volume":"92","author":"S Yamamoto","year":"2010","unstructured":"Yamamoto, S., Charng, W. L. & Bellen, H. J. Endocytosis and intracellular trafficking of Notch and its ligands. Curr. Top. Dev. Biol. 92, 165\u2013200 (2010).","journal-title":"Curr. Top. Dev. Biol."},{"key":"1185_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-0854.2010.01126.x","volume":"12","author":"S Le Bras","year":"2011","unstructured":"Le Bras, S., Loyer, N. & Le Borgne, R. The multiple facets of ubiquitination in the regulation of notch signaling pathway. Traffic 12, 149\u2013161 (2011).","journal-title":"Traffic"},{"key":"1185_CR64","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.devcel.2009.03.010","volume":"16","author":"ME Fortini","year":"2009","unstructured":"Fortini, M. E. Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 16, 633\u2013647 (2009).","journal-title":"Dev. Cell"},{"key":"1185_CR65","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.1074\/jbc.M108552200","volume":"277","author":"BM Jehn","year":"2002","unstructured":"Jehn, B. M., Dittert, I., Beyer, S., von der Mark, K. & Bielke, W. c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1. J. Biol. Chem. 277, 8033\u20138040 (2002).","journal-title":"J. Biol. Chem."},{"key":"1185_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.201302909","volume":"6","author":"A Rustighi","year":"2014","unstructured":"Rustighi, A. et al. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol. Med 6, 99\u2013119 (2014).","journal-title":"EMBO Mol. Med"},{"key":"1185_CR67","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek, M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111, 5446\u20135456 (2008).","journal-title":"Blood"},{"key":"1185_CR68","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1","volume":"40","author":"JL Binet","year":"1977","unstructured":"Binet, J. L. et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 40, 855\u2013864 (1977).","journal-title":"Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1185-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1185-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1185-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:02:43Z","timestamp":1672671763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1185-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":68,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1185-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"15 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1160"}}